Pfizer Inc. agreed to plead guilty under a $2.3 billion federal settlement over unlawful prescription-drug promotions.The company in January disclosed it would pay the $2.3 billion over allegations it had marketed the since-withdrawn anti-inflammatory drug Bextra and possibly other products for medical conditions different than their approved use. Details of the settlement weren't available in January, however.
The final agreement, announced Wednesday, also resolves Justice Department investigations involving alleged past off-label promotional practices concerning Zyvox, Geodon and Lyrica and allegations related to certain payments to health-care professionals Pfizer medicines.
Pfizer Settlement Includes Guilty Plea
A Pennsylvania court on Monday said that the state’s constitution guarantees a right to abortion while...
Donald Trump has selected Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC),...
When Bug got home from school one winter afternoon in late 2024, his mother was on...
More than 3.1 million bottles of eye drops sold at major retailers, including Walgreens and CVS,...
